A clinical trail to study the effect of nebulisation using ayurveda medicine in children with Bronchial asthma

A Clinical Study To Evaluate The Efficacy Of Bharngimool Arka Nebulization And Sinhyadi Kwath In The Management Of Tamaka Shwasa In Children

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044853

Enrollment

Registered

2022-08-23

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children of age group of 3 -16 years irrespective of caste, sex, religion. 2. Presence of classical symptoms of Tamak Shwasa like: Ghurghurkanvitam(wheezing), Shwasakashtata (shortness of breath), Aasino labhyate Saukhayam (relief in sitting position), Kasa(cough), Jawara abhibhut (associated with fever). 3. Parents of children are willing to participate in research trial.

Exclusion criteria

Exclusion criteria: 1.Patients presenting with severe symptoms of Tamak Shwasa (Bronchial asthma). 2. Any chronic illness, systemic disease like; TB, Respiratory Distress Syndrome, Chronic lung disease, Bronchiectasis, Pleurisy, CHD, Acute Diarrhoea,Septic Shock etc will be excluded from the study. 3. Children with any congenital abnormality. 4. History of food or drug allergy of any kind. 5. During course of treatment if the patient develops any acute illness requiring acute management, such patients will be excluded from the study and continued with conventional treatment. 6. Patients below age of 3 years and above 16 years

Design outcomes

Primary

Measure	Time frame
Change in subjective and objective criterias of Tamaka Shwasa Timepoint: Group A- 15 min of nebulization thrice a day for 21 days. Route of administration - inhalation Dose- 2 ml respule Follow up - Follow up will be done monthly for two months Group B - 15 min of nebulization thrice a day along with oral medication twice a day for 21 days. Route of administration - inhalation and oral Dose- 2 ml respule and 1.2ml/kg/day Follow up - Follow up will be done monthly for two months .	—

Measure

Time frame

Change in subjective and objective criterias of Tamaka Shwasa Timepoint: Group A- 15 min of nebulization thrice a day for 21 days. Route of administration - inhalation Dose- 2 ml respule Follow up - Follow up will be done monthly for two months Group B - 15 min of nebulization thrice a day along with oral medication twice a day for 21 days. Route of administration - inhalation and oral Dose- 2 ml respule and 1.2ml/kg/day Follow up - Follow up will be done monthly for two months .

—

Secondary

Measure	Time frame
1. To develop a safe and effective drug that can be helpful for asthmatic community. 2. To study etiopathogenesis of Tamak Shwasa from Ayurveda and Modern point of view. 3. To evaluate the effect of Pathya and Apathya counselling in the management of Tamak Shwasa. Timepoint: 2 months	—

Countries

India

Contacts

Public ContactDr Sunaina

Shri krishna govt ayurvedic College and hospital, kurukshetra, Haryana

324sunaina@gmail.com09671423885

Outcome results